BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu W, Song J, Du X, Zhou Y, Li Y, Li R, Lyu L, He Y, Hao J, Ben J, Wang W, Shi H, Wang Q. AKR1B10 (Aldo-keto reductase family 1 B10) promotes brain metastasis of lung cancer cells in a multi-organ microfluidic chip model. Acta Biomater 2019;91:195-208. [PMID: 31034948 DOI: 10.1016/j.actbio.2019.04.053] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 15.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang D, Cong Y, Deng Q, Han X, Zhang S, Zhao L, Luo Y, Zhang X. Physiological and Disease Models of Respiratory System Based on Organ-on-a-Chip Technology. Micromachines (Basel) 2021;12:1106. [PMID: 34577749 DOI: 10.3390/mi12091106] [Reference Citation Analysis]
2 Jia X, Yang X, Luo G, Liang Q. Recent progress of microfluidic technology for pharmaceutical analysis. J Pharm Biomed Anal 2021;209:114534. [PMID: 34929566 DOI: 10.1016/j.jpba.2021.114534] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
3 Esmaeili J, Barati A, Ai J, Nooshabadi VT, Mirzaei Z. Employing hydrogels in tissue engineering approaches to boost conventional cancer-based research and therapies. RSC Adv 2021;11:10646-69. [PMID: 35423538 DOI: 10.1039/d1ra00855b] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Nossa R, Costa J, Cacopardo L, Ahluwalia A. Breathing in vitro: Designs and applications of engineered lung models. J Tissue Eng 2021;12:20417314211008696. [PMID: 33996022 DOI: 10.1177/20417314211008696] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chabert C, Vitte AL, Iuso D, Chuffart F, Trocme C, Buisson M, Poignard P, Lardinois B, Debois R, Rousseaux S, Pepin JL, Martinot JB, Khochbin S. AKR1B10, One of the Triggers of Cytokine Storm in SARS-CoV2 Severe Acute Respiratory Syndrome. Int J Mol Sci 2022;23:1911. [PMID: 35163833 DOI: 10.3390/ijms23031911] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Fares J, Kanojia D, Rashidi A, Ulasov I, Lesniak MS. Genes that Mediate Metastasis across the Blood-Brain Barrier. Trends Cancer 2020;6:660-76. [PMID: 32417182 DOI: 10.1016/j.trecan.2020.04.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
7 Kim J, Kim W, Ahn J, Jang YJ, Park H, Jeon JS. Investigation on the Effect of Cyclic Stretch and Hypoxia on Recovery of Damaged Skeletal Muscle Cells Using Microfluidic System. Adv Materials Technologies 2021;6:2100465. [DOI: 10.1002/admt.202100465] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Nii T, Tabata Y. Immunosuppressive mesenchymal stem cells aggregates incorporating hydrogel microspheres promote an in vitro invasion of cancer cells. Regen Ther 2021;18:516-22. [PMID: 34977285 DOI: 10.1016/j.reth.2021.11.006] [Reference Citation Analysis]
9 Amirifar L, Shamloo A, Nasiri R, de Barros NR, Wang ZZ, Unluturk BD, Libanori A, Ievglevskyi O, Diltemiz SE, Sances S, Balasingham I, Seidlits SK, Ashammakhi N. Brain-on-a-chip: Recent advances in design and techniques for microfluidic models of the brain in health and disease. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121531] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
10 Gonçalves IM, Rodrigues RO, Moita AS, Hori T, Kaji H, Lima RA, Minas G. Recent trends of biomaterials and biosensors for organ-on-chip platforms. Bioprinting 2022;26:e00202. [DOI: 10.1016/j.bprint.2022.e00202] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
11 Ronaldson-Bouchard K, Baldassarri I, Tavakol DN, Graney PL, Samaritano M, Cimetta E, Vunjak-Novakovic G. Engineering complexity in human tissue models of cancer. Adv Drug Deliv Rev 2022;184:114181. [PMID: 35278521 DOI: 10.1016/j.addr.2022.114181] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Kim H, Han H, Jeong M, Han J, Park JH. Management of lymph node metastasis via local chemotherapy can prevent distant metastasis and improve survival in mice. J Control Release 2021;329:847-57. [PMID: 33065097 DOI: 10.1016/j.jconrel.2020.10.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Gao Y, Peng H, Li L, Wang F, Meng J, Huang H, Wang S, Li PCH, Sun Y. Screening of high-efficiency and low-toxicity antitumor active components in Macleaya cordata seeds based on the competitive effect of drugs on double targets by a new laminar flow chip. Analyst 2021;146:4934-44. [PMID: 34254080 DOI: 10.1039/d1an00754h] [Reference Citation Analysis]
14 Youhanna S, Kemas AM, Preiss L, Zhou Y, Shen JX, Cakal SD, Paqualini FS, Goparaju SK, Shafagh RZ, Lind JU, Sellgren CM, Lauschke VM. Organotypic and Microphysiological Human Tissue Models for Drug Discovery and Development-Current State-of-the-Art and Future Perspectives. Pharmacol Rev 2022;74:141-206. [PMID: 35017176 DOI: 10.1124/pharmrev.120.000238] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Banerjee S. Aldo Keto Reductases AKR1B1 and AKR1B10 in Cancer: Molecular Mechanisms and Signaling Networks. Adv Exp Med Biol 2021. [PMID: 33945128 DOI: 10.1007/5584_2021_634] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Büküm N, Novotná E, Morell A, Želazková J, Laštovičková L, Čermáková L, Portillo R, Solich P, Wsól V. Inhibition of AKR1B10-mediated metabolism of daunorubicin as a novel off-target effect for the Bcr-Abl tyrosine kinase inhibitor dasatinib. Biochem Pharmacol 2021;192:114710. [PMID: 34339712 DOI: 10.1016/j.bcp.2021.114710] [Reference Citation Analysis]
17 Li C, Nie W, Guo J, Xiong A, Zhong H, Chu T, Zhong R, Xu J, Lu J, Zheng X, Zhang B, Shen Y, Pan F, Han B, Zhang X. Osimertinib alone as second-line treatment for brain metastases (BM) control may be more limited than for non-BM in advanced NSCLC patients with an acquired EGFR T790M mutation. Respir Res 2021;22:145. [PMID: 33975616 DOI: 10.1186/s12931-021-01741-9] [Reference Citation Analysis]
18 Zhu Y, Mandal K, Hernandez AL, Kawakita S, Huang W, Bandaru P, Ahadian S, Kim H, Jucaud V, Dokmeci MR, Khademhosseini A. State of the art in integrated biosensors for organ-on-a-chip applications. Current Opinion in Biomedical Engineering 2021;19:100309. [DOI: 10.1016/j.cobme.2021.100309] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
19 Endo S, Matsunaga T, Nishinaka T. The Role of AKR1B10 in Physiology and Pathophysiology. Metabolites 2021;11:332. [PMID: 34063865 DOI: 10.3390/metabo11060332] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Liu W, Zhou Y, Duan W, Song J, Wei S, Xia S, Wang Y, Du X, Li E, Ren C, Wang W, Zhan Q, Wang Q. Glutathione peroxidase 4-dependent glutathione high-consumption drives acquired platinum chemoresistance in lung cancer-derived brain metastasis. Clin Transl Med 2021;11:e517. [PMID: 34586745 DOI: 10.1002/ctm2.517] [Reference Citation Analysis]
21 Katopodis P, Dong Q, Halai H, Fratila CI, Polychronis A, Anikin V, Sisu C, Karteris E. In Silico and In Vitro Analysis of lncRNA XIST Reveals a Panel of Possible Lung Cancer Regulators and a Five-Gene Diagnostic Signature. Cancers (Basel) 2020;12:E3499. [PMID: 33255394 DOI: 10.3390/cancers12123499] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Kim MH, van Noort D, Sung JH, Park S. Organ-on-a-Chip for Studying Gut-Brain Interaction Mediated by Extracellular Vesicles in the Gut Microenvironment. Int J Mol Sci 2021;22:13513. [PMID: 34948310 DOI: 10.3390/ijms222413513] [Reference Citation Analysis]
23 Del Piccolo N, Shirure VS, Bi Y, Goedegebuure SP, Gholami S, Hughes CCW, Fields RC, George SC. Tumor-on-chip modeling of organ-specific cancer and metastasis. Adv Drug Deliv Rev 2021;175:113798. [PMID: 34015419 DOI: 10.1016/j.addr.2021.05.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
24 Xie S, Wu Z, Qi Y, Wu B, Zhu X. The metastasizing mechanisms of lung cancer: Recent advances and therapeutic challenges. Biomed Pharmacother 2021;138:111450. [PMID: 33690088 DOI: 10.1016/j.biopha.2021.111450] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
25 Hakim M, Kermanshah L, Abouali H, Hashemi HM, Yari A, Khorasheh F, Alemzadeh I, Vossoughi M. Unraveling Cancer Metastatic Cascade Using Microfluidics-based Technologies. Biophys Rev. [DOI: 10.1007/s12551-022-00944-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Rodrigues RO, Sousa PC, Gaspar J, Bañobre‐lópez M, Lima R, Minas G. Organ‐on‐a‐Chip: A Preclinical Microfluidic Platform for the Progress of Nanomedicine. Small 2020;16:2003517. [DOI: 10.1002/smll.202003517] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 9.5] [Reference Citation Analysis]
27 Radhakrishnan J, Varadaraj S, Dash SK, Sharma A, Verma RS. Organotypic cancer tissue models for drug screening: 3D constructs, bioprinting and microfluidic chips. Drug Discovery Today 2020;25:879-90. [DOI: 10.1016/j.drudis.2020.03.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
28 Song J, Wang W, Wang Y, Qin Y, Wang Y, Zhou J, Wang X, Zhang Y, Wang Q. Epithelial-mesenchymal transition markers screened in a cell-based model and validated in lung adenocarcinoma. BMC Cancer 2019;19:680. [PMID: 31296175 DOI: 10.1186/s12885-019-5885-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
29 Wang X, Hou Y, Ai X, Sun J, Xu B, Meng X, Zhang Y, Zhang S. Potential applications of microfluidics based blood brain barrier (BBB)-on-chips for in vitro drug development. Biomed Pharmacother 2020;132:110822. [PMID: 33059264 DOI: 10.1016/j.biopha.2020.110822] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
30 Wei S, Liu W, Xu M, Qin H, Liu C, Zhang R, Zhou S, Li E, Liu Z, Wang Q. Cathepsin F and Fibulin-1 as novel diagnostic biomarkers for brain metastasis of non-small cell lung cancer. Br J Cancer 2022. [PMID: 35217799 DOI: 10.1038/s41416-022-01744-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Xu M, Wang Y, Duan W, Xia S, Wei S, Liu W, Wang Q. Proteomic Reveals Reasons for Acquired Drug Resistance in Lung Cancer Derived Brain Metastasis Based on a Newly Established Multi-Organ Microfluidic Chip Model. Front Bioeng Biotechnol 2020;8:612091. [PMID: 33415100 DOI: 10.3389/fbioe.2020.612091] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Liu W, Powell CA, Wang Q. Tumor microenvironment in lung cancer-derived brain metastasis. Chin Med J (Engl) 2022. [PMID: 35838548 DOI: 10.1097/CM9.0000000000002127] [Reference Citation Analysis]
33 Shao X, Wu J, Yu S, Zhou Y, Zhou C. AKR1B10 inhibits the proliferation and migration of gastric cancer via regulating epithelial-mesenchymal transition. Aging (Albany NY) 2021;13:22298-314. [PMID: 34552036 DOI: 10.18632/aging.203538] [Reference Citation Analysis]
34 Luo L, Liu P, Zhao K, Zhao W, Zhang X. The Immune Microenvironment in Brain Metastases of Non-Small Cell Lung Cancer. Front Oncol 2021;11:698844. [PMID: 34336687 DOI: 10.3389/fonc.2021.698844] [Reference Citation Analysis]
35 Guan M, Tang S, Chang H, Chen Y, Chen F, Mu Y, Zhao D, Fan W, Tian H, Darland DC, Zhang Y. Development of alveolar-capillary-exchange (ACE) chip and its application for assessment of PM2.5-induced toxicity. Ecotoxicol Environ Saf 2021;223:112601. [PMID: 34385060 DOI: 10.1016/j.ecoenv.2021.112601] [Reference Citation Analysis]
36 Cao Z, Delfino K, Tiwari V, Wang X, Hannan A, Zaidi F, McClintock A, Robinson K, Zhu Y, Gao J, Cao D, Rao K. AKR1B10 as a Potential Novel Serum Biomarker for Breast Cancer: A Pilot Study. Front Oncol 2022;12:727505. [PMID: 35280770 DOI: 10.3389/fonc.2022.727505] [Reference Citation Analysis]
37 Vargas R, Egurbide-Sifre A, Medina L. Organ-on-a-Chip systems for new drugs development. ADMET DMPK 2021;9:111-41. [PMID: 35299767 DOI: 10.5599/admet.942] [Reference Citation Analysis]
38 Lin L, Wang X, Niu M, Wu Q, Wang H, Zu Y, Wang W. Biomimetic epithelium/endothelium on chips. Engineered Regeneration 2022. [DOI: 10.1016/j.engreg.2022.05.001] [Reference Citation Analysis]
39 Ito A, Akama Y, Satoh-takayama N, Saito K, Kato T, Kawamoto E, Gaowa A, Park EJ, Takao M, Shimaoka M. Possible Metastatic Stage-Dependent ILC2 Activation Induces Differential Functions of MDSCs through IL-13/IL-13Rα1 Signaling during the Progression of Breast Cancer Lung Metastasis. Cancers 2022;14:3267. [DOI: 10.3390/cancers14133267] [Reference Citation Analysis]
40 Mondadori C, Crippa M, Moretti M, Candrian C, Lopa S, Arrigoni C. Advanced Microfluidic Models of Cancer and Immune Cell Extravasation: A Systematic Review of the Literature. Front Bioeng Biotechnol 2020;8:907. [PMID: 32984267 DOI: 10.3389/fbioe.2020.00907] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
41 Nii T, Makino K, Tabata Y. Three-Dimensional Culture System of Cancer Cells Combined with Biomaterials for Drug Screening. Cancers (Basel) 2020;12:E2754. [PMID: 32987868 DOI: 10.3390/cancers12102754] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
42 Chen D, Shen Z, Cheng X, Wang Q, Zhou J, Ren F, Sun Y, Wang H, Huang R. Homeobox A5 activates p53 pathway to inhibit proliferation and promote apoptosis of adrenocortical carcinoma cells by inducing Aldo-Keto reductase family 1 member B10 expression. Bioengineered 2021;12:1964-75. [PMID: 34027794 DOI: 10.1080/21655979.2021.1924545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Liang Y, Yoon J. In situ sensors for blood-brain barrier (BBB) on a chip. Sensors and Actuators Reports 2021;3:100031. [DOI: 10.1016/j.snr.2021.100031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]